Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01549860
Other study ID # IN-BALANCE VLU
Secondary ID
Status Completed
Phase N/A
First received March 7, 2012
Last updated July 2, 2015
Start date April 2012
Est. completion date April 2015

Study information

Verified date July 2015
Source Celleration, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This trial is a prospective, randomized, controlled, multi-center study of subjects presenting with chronic lower extremity venous ulcers. The study will evaluate the safety and effectiveness of MIST Therapy® plus standard of care (MIST+SOC) compared to Standard of Care (SOC) alone in the treatment of lower extremity venous ulcers.


Description:

The study compared the treatment effect of non-contact low frequency ultrasound in addition to standard of care versus standard of care alone in healing chronic venous leg ulcers in subjects who had documented venous stasis and reflux. Subjects that were screened and met the major inclusion criteria received standardized treatment of 30 to 40 mmHg compression, moist wound healing dressings, and debridement for a two week run-in period. If their study ulcer did not decreased by greater than 30% they were eligible for randomization. The primary endpoint was wound area reduction after four (4) weeks of study treatment. The study was performed at 22 study centers. The study included two sub-studies: fluid and tissue analysis and a wound recidivism registry that are ongoing.


Recruitment information / eligibility

Status Completed
Enrollment 156
Est. completion date April 2015
Est. primary completion date May 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Lower extremity full thickness venous ulcer of > 30 days duration

- Subject's wound must be between 4 cm² and 50 cm² at screening

- Documented ABI that is between 0.8 and 1.2 on the study limb or transcutaneous partial pressure oxygen (TcpO2) > 40 mmHG; or a toe pressure > 40 mmHG; or a Doppler waveform consistent with adequate flow in the foot (biphasic or triphasic waveforms) at time of screening

- Biopsy for wounds > 6 months duration

- Documented index wound etiology of venous stasis with reflux and /or incompetent valves

Exclusion Criteria:

- Index ulcer wound that is less than 1 cm in distance from another ulcer wound

- > 5 ulcers on the index leg

- Index ulcer wound has exposed tendons, ligaments, muscle, or bone

- Index ulcer wound presents with clinical signs of acute infection, suspected or known

- Subjects with evidence of osteomyelitis or cellulitis or gangrene in the study limb

- Subjects with amputation above a Trans Metatarsal Amputation (TMA) in the study limb

- Subjects with active malignancy on the study limb except non-melanoma skin cancer

- Index ulcer that is of arterial disease etiology

- Index ulcer of other primary etiology (ie. vasculitis, arterial, pyoderma)

- Subjects with planned vascular surgery, angioplasty or thrombolysis procedures within the study treatment phase

- Subjects with planned surgical procedure during the study treatment phase for the index wound including skin flap or skin graft

- Subjects within 6 weeks postoperatively of a vascular o skin graft procedure.

- Subject has had prior skin replacement, negative pressure therapy, or traditional ultrasound therapy applied to the index wound in the 14 days prior to screening

- Subject has had ultrasound treatment (including MIST Therapy) of the index wound.

- Subject has received growth factor therapy (e.g., autologous platelet-rich plasma gel, becaplermin, bilayered cell therapy, dermal substitute, extracellular matrix) within 14 days of screening date.

- Subject is currently receiving or has received radiation or chemotherapy within 3 months of randomization.

- Female subjects that are pregnant or refuse to utilize adequate contraceptive methods and are of childbearing age during the trial.

- Subject has one or more medical condition(s), uncontrolled diabetes (i.e. HbA1c > 12), renal, hepatic, hematologic, neurologic, or immune disease that in the opinion of the investigator would make the subject an inappropriate study candidate

- Subject's wound would require ultrasound near an electronic implant or prosthesis

- Subject is known to be suffering from a disorder or other situation that the subject or investigator feels would interfere with compliance or other study requirements

- Subject is currently enrolled or has been enrolled in the last 30 days in another investigational device or drug trial

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Intervention

Device:
MIST Therapy
Non-contact low frequency ultrasound therapy

Locations

Country Name City State
United States South Shore Hospital Weymouth Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Celleration, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Wound Area Mean Percent Reduction Compare between the treatment groups percent wound area reduction at four weeks of study treatment.
H0: µMIST+SC -- µSC = 0 HA: µMIST+SC -- µSC ? 0 Where µ = percent reduction in wound size.
4 weeks post baseline visit (randomization visit) No
Secondary Heal Rates Compare rate of wound closure between study arms for 12 weeks post randomization. Descriptive statistics as not a powered endpoint. 12 weeks post randomization No
Secondary Change in Pain VAS Scores Compare VAS Pain Scores between arms at baseline and 4 weeks post randomization
Subjects indicate their pain level by drawing a mark on a 10 cm line on a visual analog scale (VAS) at randomization and 4 week post treatment visit. The left end of the line indicates "no pain" and the right end of line indicates "worst pain imaginable". VAS score is determined by using a ruler placed at 0 (left end of scale) and measuring the distance from zero to the patient's mark . The objective is to compare the change in VAS values in MIST+SC to SC alone.
H0: The average change in pain level is not different between MIST and SC HA: The average change in pain level is different between MIST and SC H0: µMIST = µSC vs HA: µMIST ? µSC,
Statistical Analysis. A repeated measures ANCOVA will be used to test for differences in change in VAS with an indicator variable to indicate treatment, any demographic variables which were significant in the baseline comparisons.
Baseline, 2 weeks and 4 weeks post randomization No
See also
  Status Clinical Trial Phase
Completed NCT05507346 - A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema N/A
Completed NCT04469361 - The Effect of Training on Hemodynamic Factors in Ballet Dancer
Recruiting NCT05633277 - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections N/A
Completed NCT03283800 - Copper Impact on Venous Insufficiency and Lipodermatosclerosis N/A
Terminated NCT03311269 - A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency Phase 2
Withdrawn NCT01680809 - Compliance of Compression Therapy in Healed Venous Ulcerations N/A
Completed NCT00617825 - Feasibility Study of Cryotherapy for Chronic Venous Disorders N/A
Active, not recruiting NCT00270972 - The Evaluation of OrCel for the Treatment of Venous Ulcers N/A
Completed NCT01701661 - Compression Therapy Versus Surgery in the Treatment of Superficial Venous Reflux N/A
Active, not recruiting NCT06369207 - Investigation of the Transmission Pathways of Reflux in Patients With Chronic Venous Insufficiency
Completed NCT04461132 - The Effect of Manual Lymphatic Drainage N/A
Recruiting NCT04546750 - Prospective Cohort Study for Varicose Veins Incidence and Natural Course
Not yet recruiting NCT03543007 - Evaluating the Safety and Efficacy of GrafixPL™PRIME for the Treatment of Chronic Venous Leg Ulcers N/A
Active, not recruiting NCT02397226 - Lower Limb Venous Insufficiency and the Effect of Radiofrequency Treatment Versus Open Surgery N/A
Not yet recruiting NCT01110512 - Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI) Phase 3
Completed NCT00565604 - Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins N/A
Completed NCT01298908 - Comparison of Treatments in Venous Insufficiency N/A
Active, not recruiting NCT00841178 - Endovenous Laser Therapy (EVLT) for Sapheno-Popliteal Incompetence and Short Saphenous Vein (SSV) Reflux: A RCT N/A
Not yet recruiting NCT03652025 - The Effectiveness of Trans-catheter Foam Sclerotherapy of Pelvic and Atypical Lower Limb Varicosities N/A
Completed NCT03755180 - Exercise Training in Venous Insufficiency N/A